Loading…
VolitionRx Limited is projected to decline to $2.53 by 2027, a -14% move from its current price of $2.94. VNRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.77 | $2.94 | $3.13 | +0.01% |
| May 30 | $2.70 | $2.94 | $3.21 | +0.03% |
| May 31 | $2.65 | $2.94 | $3.27 | +0.04% |
| Jun 1 | $2.60 | $2.94 | $3.32 | +0.06% |
| Jun 2 | $2.57 | $2.94 | $3.37 | +0.07% |
| Jun 3 | $2.53 | $2.94 | $3.42 | +0.09% |
| Jun 4 | $2.51 | $2.94 | $3.46 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.51 | $2.94 | $3.46 | +0.10% |
| Week 2 | $2.35 | $2.95 | $3.70 | +0.20% |
| Week 3 | $2.23 | $2.95 | $3.90 | +0.31% |
| Week 4 | $2.14 | $2.95 | $4.07 | +0.41% |
| Week 5 | $2.06 | $2.96 | $4.24 | +0.51% |
| Week 6 | $1.99 | $2.96 | $4.39 | +0.62% |
| Week 7 | $1.93 | $2.96 | $4.54 | +0.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
VolitionRx Limited (VNRX) is a healthcare company operating in the epigenetics space. It develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet for cancer screening in dogs and other animals; Nu.Q Nets for detecting NETosis-related diseases such as sepsis; Nu.Q Discover for profiling nucleosomes; Nu.Q Cancer for predicting treatment response and monitoring progression, and amending cancer treatment regimens; along with Capture-PCR and Capture-Seq to isolate and capture circulating tumor-derived DNA from plasma samples for early cancer detection.
VolitionRx Limited is headquartered in Henderson, Nevada.
VolitionRx Limited is a healthcare stock (epigenetics-focused) trading at $3.13 per share with a market capitalization of $26.07M and a rank of 4866. The current price sits near a defined technical framework and the stock is positioned within a broader forecast that spans multiple years, showing a wide potential range of outcomes. Forecasts project varying yearly paths, with notable acceleration projected toward the late-2020s and into the 2030s and beyond, including higher average prices by 2032, 2040, and 2050.
A major floor 57.6% below — a decisive break under it would weaken the trend.
The nearest floor, 32.0% below — buyers have tended to step in here.
The nearest ceiling, 22.4% above — a clean break opens room to run.
A major ceiling 117.7% above — clearing it would confirm fresh momentum.
Key VNRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VNRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.84 | Buy | $2.83 | Buy |
| MA 10 | $2.54 | Buy | $2.67 | Buy |
| MA 20 | $2.47 | Buy | $2.65 | Buy |
| MA 50 | $3.09 | Sell | $3.09 | Sell |
| MA 100 | $4.03 | Sell | $4.11 | Sell |
| MA 200 | $6.77 | Sell | $6.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.40 | Neutral |
| Stoch RSI (14) | 86.90 | Sell |
| CCI (20) | 142.32 | Buy |
| Williams %R (14) | -16.81 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | 30.67 | Buy |
| Bollinger %B (20,2) | 0.92 | Neutral |
| Stochastic %K (14) | 83.19 | Sell |
| TRIX (15) | -1.08 | Sell |
| Awesome (5,34) | 0.08 | Buy |
| Ultimate (7,14,28) | 71.77 | Sell |
| Momentum (10) | 0.62 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 3.15 | Sell |
| ADX (14) | 27.35 | Buy |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is bullish overall. The RSI(14) is 60, signaling neither overbought nor oversold momentum as near-term dynamics unfold. The stock’s simple moving averages sit at $3.12 for the SMA-50 and $6.87 for the SMA-200, with a support level at $2.00 and a resistance level at $3.60.
The most recent 30-day trading range runs from $2.06 up to $4.76, highlighting the near-term volatility. Annualized volatility stands at 100%, underscoring material price swings over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.00 | $2.94 | $4.16 | 0% | Neutral | |
| $1.82 | $2.53 | $3.81 | -14% | Neutral | |
| $1.55 | $2.28 | $3.65 | -22% | Bearish | |
| $1.77 | $2.75 | $4.60 | -7% | Neutral | |
| $1.89 | $3.07 | $5.35 | +4% | Neutral | |
| $2.08 | $3.53 | $6.37 | +20% | Bullish | |
| $2.11 | $3.74 | $6.95 | +27% | Bullish | |
| $1.80 | $3.32 | $6.34 | +13% | Neutral | |
| $1.57 | $3.02 | $5.91 | +3% | Neutral | |
| $1.44 | $2.88 | $5.76 | -2% | Neutral | |
| $1.86 | $4.13 | $9.09 | +41% | Bullish | |
| $4.36 | $9.70 | $22.31 | +230% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.00 | $2.94 | $3.52 | +0.00% |
| June 2026 | $2.54 | $3.05 | $3.79 | +3.78% |
| July 2026 | $2.44 | $2.98 | $3.80 | -2.34% |
| August 2026 | $2.51 | $3.11 | $4.04 | +4.28% |
| September 2026 | $2.62 | $3.28 | $4.33 | +5.54% |
| October 2026 | $2.50 | $3.15 | $4.22 | -3.83% |
| November 2026 | $2.34 | $2.98 | $4.04 | -5.38% |
| December 2026 | $2.36 | $3.04 | $4.16 | +1.77% |
Click any year to see its month-by-month VNRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, VNRX is projected to trade between $2.00 and $4.16, averaging $2.94 — a potential gain of 0% from today's $2.94. A consolidation phase looks the most probable path here.
VolitionRx Limited's 2027 outlook centres on $2.53, within a $1.82 to $3.81 range. That is -14% versus the projected 2026 average. That marks a -14% change versus current levels. Price action looks broadly range-bound.
By 2028, VNRX could reach as high as $3.65, with a base case around $2.28 and support toward $1.55 — roughly -22% from $2.94. Expect choppier, lower action through this leg of the cycle.
Expect VNRX to range from $1.77 to $4.60 through 2029. The $2.75 average target implies a -7% move from current prices. That is up +20% on the projected 2028 average. Price action looks broadly range-bound.
The VNRX price prediction for 2030 points to an average of $3.07 (low $1.89, high $5.35) — a potential gain of +4% on today's $2.94. A consolidation phase looks the most probable path here.
In 2031, VNRX is projected to trade between $2.08 and $6.37, averaging $3.53 — a potential gain of +20% from today's $2.94. That is up +15% on the projected 2030 average. Momentum favours further upside here.
VolitionRx Limited's 2032 outlook centres on $3.74, within a $2.11 to $6.95 range. That is up +6% on the projected 2031 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, VNRX could reach as high as $6.34, with a base case around $3.32 and support toward $1.80 — roughly +13% from $2.94. Price action looks broadly range-bound.
Expect VNRX to range from $1.57 to $5.91 through 2034. The $3.02 average target implies a +3% move from current prices. That is -9% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The VNRX price prediction for 2035 points to an average of $2.88 (low $1.44, high $5.76) — a potential decline of -2% on today's $2.94. Price action looks broadly range-bound.
In 2040, VNRX is projected to trade between $1.86 and $9.09, averaging $4.13 — a potential gain of +41% from today's $2.94. That is up +44% on the projected 2035 average. Buyers look set to stay in control over this stretch.
VolitionRx Limited's 2050 outlook centres on $9.70, within a $4.36 to $22.31 range. That is up +135% on the projected 2040 average. That marks a +230% change versus current levels. Momentum favours further upside here.
Investing $1,000 in VNRX today (≈ 340.136054 VNRX) could be worth
$3,299.2
+$2,299.2 (+230%) by 2050 · US Dollar
Based on the average projected VNRX price of $9.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VNRXwould be worth at today's price.
$1,000 invested in VNRX on May 27, 2025 (≈ 104.166663 VNRX) would be worth
$306.25
-$693.75 (-69.4%) today · 0.31× · US Dollar
Based on a VNRX entry price of $9.6 vs. today's $2.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.49 | $1,180.72 | +18.1% |
| 1 month ago | $2.8 | $1,050 | +5.0% |
| 3 months ago | $4.8 | $612.5 | -38.8% |
| 6 months ago | $6.4 | $459.37 | -54.1% |
| 1 year ago | $9.6 | $306.25 | -69.4% |
| All time (5.0y) ago | $70.2 | $41.88 | -95.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VNRX forecast.
Our base-case forecast reaches $5.90 around 2050.
Implied market cap at $5.90: $49.15M
The multi-year forecast shows a varied path across years, with some years delivering negative returns and others showing meaningful upside. For 2030 the average price is $3.20 with a 2.4% ROI and neutral sentiment (min $1.97, max $5.59). The outlook features several fluctuations in the 2027–2035 window, including negative ROIs in 2027 (-14.5%), 2028 (-22.6%), and 2035 (-1.4%), before a return to positive momentum by 2031 and 2032 (e.g., 2032 avg $4.00, ROI 27.9%, sentiment bullish).
By 2040 the average price is projected at $4.40 with a 40.6% ROI and bullish sentiment, and by 2050 the average price could reach $10.23 with a 226.9% ROI and bullish sentiment (max in 2050 $23.53). These figures illustrate a wide potential trajectory rather than a guaranteed outcome, with upside potential in the long run but also periods of contraction and high volatility. Drivers and risks reflect the earnings, volatility, and market dynamics implied by the year-by-year numbers, recognizing that these are estimates, not guarantees.
Tap a question to reveal the answer.
2030 min $1.97, avg $3.20, max $5.59; ROI 2.4%; sentiment NEUTRAL.
The forecast shows a mix of neutral and bullish years, with several years of negative ROIs (e.g., 2027 -14.5%, 2028 -22.6%, 2035 -1.4%), and notable upside by 2050 (ROI 226.9%, bullish). These are estimates, not guarantees.
Yes, the 2050 forecast shows an avg price of $10.23 and a max of $23.53 with a 226.9% ROI and bullish sentiment.
Current price is $3.13.
Sentiment is BULLISH. RSI(14) is 60; SMA-50 is $3.12; SMA-200 is $6.87; support is $2.00 and resistance is $3.60. The 30-day range is $2.06 to $4.76; annualized volatility is 100%.
VolitionRx Limited Community Discussion
0Share your VolitionRx Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.